- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
Krystal Biotech is a biotechnology business based in the US. Krystal Biotech shares (KRYS) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $156.64 – a decrease of 9.67% over the previous week. Krystal Biotech employs 229 staff and has a trailing 12-month revenue of around $241.5 million.
What's in this guide?
Our top picks for where to buy Krystal Biotech stock
- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you fund a new account within 30 days
- Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%
How to buy Krystal Biotech stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – KRYS. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Krystal Biotech stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 4 of 4
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Krystal Biotech stock price (NASDAQ: KRYS)
Use our graph to track the performance of KRYS stocks over time.Krystal Biotech shares at a glance
Information last updated 2024-12-12.
| Latest market close | $156.64 |
|---|---|
| 52-week range | $107.50 - $219.34 |
| 50-day moving average | $181.09 |
| 200-day moving average | $179.48 |
| Wall St. target price | $207.78 |
| PE ratio | 105.1236 |
| Dividend yield | N/A |
| Earnings per share (TTM) | $1.78 |
Is it a good time to buy Krystal Biotech stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Krystal Biotech price performance over time
Historical closes compared with the close of $169.04 from 2024-12-17
| 1 week (2024-12-12) | -2.51% |
|---|---|
| 1 month (2024-11-20) | -5.09% |
| 3 months (2024-09-19) | -8.37% |
| 6 months (2024-06-18) | -2.29% |
| 1 year (2023-12-19) | 41.90% |
|---|---|
| 2 years (2022-12-19) | 122.51% |
| 3 years (2021-12-17) | 134.84% |
| 5 years (2019-12-19) | 201.43% |
Is Krystal Biotech stock undervalued or overvalued?
Valuing Krystal Biotech stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Krystal Biotech's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Krystal Biotech's P/E ratio
Krystal Biotech's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 105x. In other words, Krystal Biotech shares trade at around 105x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Krystal Biotech's EBITDA
Krystal Biotech's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $69.1 million.
The EBITDA is a measure of a Krystal Biotech's overall financial performance and is widely used to measure a its profitability.
Krystal Biotech financials
| Revenue TTM | $241.5 million |
|---|---|
| Operating margin TTM | 41.67% |
| Gross profit TTM | $0 |
| Return on assets TTM | 4.58% |
| Return on equity TTM | 6.38% |
| Profit margin | 21.68% |
| Book value | $30.81 |
| Market Capitalization | $5.4 billion |
TTM: trailing 12 months
Krystal Biotech share dividends
We're not expecting Krystal Biotech to pay a dividend over the next 12 months.
Krystal Biotech share price volatility
Over the last 12 months, Krystal Biotech's shares have ranged in value from as little as $107.5 up to $219.34. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Krystal Biotech's is 0.82. This would suggest that Krystal Biotech's shares are less volatile than average (for this exchange).
Krystal Biotech overview
Krystal Biotech, Inc. , a commercial-stage biotechnology company, discovers, develops, and commercializes genetic medicines for patients with rare diseases in the United States. It commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). The company also develops KB105, which is in Phase 1/2 clinical trials for treating patients with deficient autosomal recessive congenital ichthyosis; KB104 for treating netherton syndrome; KB407 that is in Phase 1 clinical trials for treating cystic fibrosis; KB707 that is in Phase 1 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania. .
Frequently asked questions
What percentage of Krystal Biotech is owned by insiders or institutions?Currently 12.303% of Krystal Biotech shares are held by insiders and 106.951% by institutions. How many people work for Krystal Biotech?
Latest data suggests 229 work at Krystal Biotech. When does the fiscal year end for Krystal Biotech?
Krystal Biotech's fiscal year ends in December. Where is Krystal Biotech based?
Krystal Biotech's address is: 2100 Wharton Street, Pittsburgh, PA, United States, 15203 What is Krystal Biotech's ISIN number?
Krystal Biotech's international securities identification number is: US5011471027 What is Krystal Biotech's CUSIP number?
Krystal Biotech's Committee on Uniform Securities Identification Procedures number is: 501147102
More resources on Finder
More guides on Finder
-
How to buy Merck-and-Company stock (MRK)
Steps to owning and managing MRK, with 24-hour and historical pricing before you buy.
-
How to buy Eli Lilly and Company stock (LLY)
Steps to owning and managing LLY, with 24-hour and historical pricing before you buy.
-
How to buy Intuitive Surgical stock (ISRG)
Steps to owning and managing ISRG, with 24-hour and historical pricing before you buy.
-
How to buy Vertex Pharmaceuticals stock (VRTX)
Steps to owning and managing VRTX, with 24-hour and historical pricing before you buy.
-
How to buy McKesson Corporation stock (MCK)
Steps to owning and managing MCK, with 24-hour and historical pricing before you buy.
-
How to buy UnitedHealth Group Incorporated stock (UNH)
Steps to owning and managing UNH, with 24-hour and historical pricing before you buy.
-
How to buy Amgen stock (AMGN)
Steps to owning and managing AMGN, with 24-hour and historical pricing before you buy.
-
How to buy Abbott Laboratories stock (ABT)
Steps to owning and managing ABT, with 24-hour and historical pricing before you buy.
-
How to buy Pfizer stock (PFE)
Steps to owning and managing PFE, with 24-hour and historical pricing before you buy.
-
How to buy Johnson & Johnson stock (JNJ)
Steps to owning and managing JNJ, with 24-hour and historical pricing before you buy.
Ask a question